| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: GTOP |
| Security Type |
Common Stock |
| Lead Underwriter |
WR Hambrecht & Co LLC |
| Days In Registration |
84 |
| Date Filed |
6-Aug-2003 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Manufacture prescription pharmaceuticals intended for final consumption, including biotech products and antibiotics |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
16.24M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
4.6M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
4.6M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
555.0K |
| File Amount |
$50.6M |
| File Price Range |
$11.00 - $11.00 |
| File Mid Price |
$11.00 |
Current Filing Information
(Amended 28-Oct-2003) |
|
US |
|
Shares Filed |
4.6M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
4.6M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$50.6M |
| · % Change from Original |
0.0 |
| File Price Range |
$11.00 - $11.00 |
| File Mid Price |
$11.00 |
|
